Skip to main content
PolicySpeak
← All files
EME

Emergent

Company · United States · EU Transparency Register 946394317378-56

1
position filed
in the 687 files tracked
1
legislative file
of 687 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 687 consultation files tracked so far (60,344 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1244 companies & groups on this site, they rank #970 by legislative files engaged, a count of participation, not a measure of influence.

1
declared lobbying FTE
self-declared
€600K+
declared costs / yr (floor)
2
EP accreditations
as declared to the register
2015
in the register since

Declares membership of

  • Emergent is a member of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs), a trade association of small…
  • Emergent is a member of PSRT (The Private Sector Roundtable on Global Health Security).
  • Emergent is a member of the US Chamber of Commerce Europe Program.
  • Emergent sponsors the Brussels Resilience Forum multi-stakeholder initiative.

Self-declared to the EU Transparency Register (snapshot 27 Oct 2026).

Register category
Companies & groups
Head office
Gaithersburg, MD, United states

Self-declared to the EU Transparency Register (snapshot 27 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Emergent in PolicySpeak: request access →

Follow Emergent

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at Emergent? so we know who speaks for it.

Their record over time

Emergent filed 1 position on 21 Oct 2026, across 1 of the 687 legislative files tracked here.

What they argued

"Diversify EU" instrumentfiled 21 Oct 2026source

Emergent welcomes the European Commission's initiative to strengthen supply chain resilience and reduce critical dependencies in strategically important sectors. As a global manufacturer of medical countermeasures (MCMs) for biological threat preparedness, we focus this response on the biodefence and medical countermeasure sector where supply chain resilience is inseparable from European health security and…

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Emergent next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Emergent’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.